Literature DB >> 21498664

TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.

Dalia E Gaddis1, Suzanne M Michalek, Jannet Katz.   

Abstract

Recombinant hemagglutinin B (rHagB), a virulence factor of the periodontal pathogen Porphyromonas gingivalis, has been shown to induce protective immunity against bacterial infection. Furthermore, we have demonstrated that rHagB is a TLR4 agonist for dendritic cells. However, it is not known how rHagB dendritic cell stimulation affects the activation and differentiation of T cells. Therefore, we undertook the present study to examine the role of TLR4 signaling in shaping the CD4(+) T cell response following immunization of mice with rHagB. Immunization with this Ag resulted in the induction of specific CD4(+) T cells and Ab responses. In TLR4(-/-) and MyD88(-/-) but not Toll/IL-1R domain-containing adapter inducing IFN-β-deficient (TRIF(Lps2)) mice, there was an increase in the Th2 CD4(+) T cell subset, a decrease in the Th1 subset, and higher serum IgG(1)/IgG(2) levels of HagB-specific Abs compared with those in wild-type mice. These finding were accompanied by increased GATA-3 and Foxp3 expression and a decrease in the activation of CD4(+) T cells isolated from TLR4(-/-) and MyD88(-/-) mice. Interestingly, TLR4(-/-) CD4(+) T cells showed an increase in IL-2/STAT5 signaling. Whereas TRIF deficiency had minimal effects on the CD4(+) T cell response, it resulted in increased IFN-γ and IL-17 production by memory CD4(+) T cells. To our knowledge, these results demonstrate for the first time that TLR4 signaling, via the downstream MyD88 and TRIF molecules, exerts a differential regulation on the CD4(+) T cell response to HagB Ag. The gained insight from the present work will aid in designing better therapeutic strategies against P. gingivalis infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498664      PMCID: PMC3809913          DOI: 10.4049/jimmunol.1003192

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  97 in total

1.  Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.

Authors:  A M Hajjar; D S O'Mahony; A Ozinsky; D M Underhill; A Aderem; S J Klebanoff; C B Wilson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

Review 2.  Role of bacterial proteinases in matrix destruction and modulation of host responses.

Authors:  J Potempa; A Banbula; J Travis
Journal:  Periodontol 2000       Date:  2000-10       Impact factor: 7.589

3.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

4.  Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.

Authors:  D J Marciani; J B Press; R C Reynolds; A K Pathak; V Pathak; L E Gundy; J T Farmer; M S Koratich; R D May
Journal:  Vaccine       Date:  2000-07-15       Impact factor: 3.641

Review 5.  Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells.

Authors:  John J O'Shea; William E Paul
Journal:  Science       Date:  2010-02-26       Impact factor: 47.728

6.  Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis.

Authors:  N J López
Journal:  J Periodontol       Date:  2000-06       Impact factor: 6.993

7.  Murine retroviruses activate B cells via interaction with toll-like receptor 4.

Authors:  John C Rassa; Jennifer L Meyers; Yuanming Zhang; Rama Kudaravalli; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells.

Authors:  Karim Dabbagh; Martin E Dahl; Pamela Stepick-Biek; David B Lewis
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization.

Authors:  Jeremy P McAleer; Bei Liu; Zihai Li; Soo-Mun Ngoi; Jie Dai; Martin Oft; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2010-02-03       Impact factor: 4.962

Review 10.  Modulation of adaptive immunity with Toll-like receptors.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Semin Immunol       Date:  2009-06-06       Impact factor: 11.130

View more
  24 in total

1.  Three conserved MyD88-recruiting TLR residues exert different effects on the human TLR4 signaling pathway.

Authors:  Yan Ding; Yuan Qiu; Linyun Zou; Zhangping Tan; Jigang Dai; Wenyue Xu
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

2.  Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis.

Authors:  Dalia E Gaddis; Craig L Maynard; Casey T Weaver; Suzanne M Michalek; Jannet Katz
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

3.  Aging and contribution of MyD88 and TRIF to expression of TLR pathway-associated genes following stimulation with Porphyromonas gingivalis.

Authors:  Y B Shaik-Dasthagirisaheb; N Huang; E O Weinberg; S S Shen; C A Genco; F C Gibson
Journal:  J Periodontal Res       Date:  2014-05-24       Impact factor: 4.419

4.  Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide.

Authors:  Pengfei Wang; Dattatray A Devalankar; Qipu Dai; Ping Zhang; Suzanne M Michalek
Journal:  J Org Chem       Date:  2016-10-13       Impact factor: 4.354

5.  Porphyromonas gingivalis exacerbates ligature-induced, RANKL-dependent alveolar bone resorption via differential regulation of Toll-like receptor 2 (TLR2) and TLR4.

Authors:  Jiang Lin; Liangjia Bi; Xiaoqian Yu; Toshihisa Kawai; Martin A Taubman; Baozhong Shen; Xiaozhe Han
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

Review 6.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

7.  Human beta defensin 3 alters matrix metalloproteinase production in human dendritic cells exposed to Porphyromonas gingivalis hemagglutinin B.

Authors:  Monica Raina; Amber M Bates; Carol L Fischer; Ann Progulske-Fox; Taher Abbasi; Shireen Vali; Kim A Brogden
Journal:  J Periodontol       Date:  2018-03       Impact factor: 6.993

8.  Synthesis of QS-21-based immunoadjuvants.

Authors:  Pengfei Wang; Qipu Dai; Punith Thogaripally; Ping Zhang; Suzanne M Michalek
Journal:  J Org Chem       Date:  2013-11-05       Impact factor: 4.354

Review 9.  A unique host defense pathway: TRIF mediates both antiviral and antibacterial immune responses.

Authors:  Jinhee Hyun; Saravana Kanagavelu; Masayuki Fukata
Journal:  Microbes Infect       Date:  2012-10-29       Impact factor: 2.700

10.  Immuno-pathogenesis of Periodontal Disease: Current and Emerging Paradigms.

Authors:  Nasi Huang; Frank C Gibson
Journal:  Curr Oral Health Rep       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.